Interactions of nitroglycerin and sulfhydryl-donating compounds in coronary microvessels. 1994

R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
Department of Medicine, Emory University, Atlanta, Georgia 30322.

Previous studies have shown the effect of nitroglycerin on coronary microvessels < 100 microns in diameter is markedly enhanced by L-cysteine. These studies were performed to examine the mechanisms responsible for this effect. Under control conditions, nitroglycerin caused potent dilations of large (> 200 microns diam) coronary microvessels while having minimal effects on small (< 100 microns diam) coronary microvessels [peak relaxations 85 +/- 4 vs. 23 +/- 3% (mean +/- SE) of endothelin-1-constricted vessels, respectively]. L-Cysteine (100 microM) and N-acetylcysteine (100 microM) markedly enhanced nitroglycerin-induced relaxations of small coronary microvessels (peak relaxation 84 +/- 6 and 87 +/- 12%, respectively) while having no effect on relaxations of vessels > 100 microns. In contrast, neither L-methionine (100 microM) nor glutathione (100 microM) enhanced nitroglycerin's vasodilation of small coronary microvessels. The effects of L-cysteine and N-acetylcysteine on the augmentation of nitroglycerin vasodilatation in smaller coronary microvessels was abolished in the presence of buthionine sulfoximine (100 microM), a potent inhibitor of intracellular glutathione synthesis. Buthionine sulfoximine had no effect on the vasodilatation produced by nitroprusside. These data demonstrate that, in smaller coronary microvessels, L-cysteine and N-acetylcysteine enhance nitroglycerin-induced vasodilatation by increasing intracellular glutathione concentrations. Intracellular glutathione, formed from either L-cysteine or N-acetylcysteine, may participate in the formation of an intermediate of nitroglycerin biotransformation or may maintain a redox potential within coronary microvessels that favors enzymatic bioconversion of nitroglycerin.

UI MeSH Term Description Entries
D008297 Male Males
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog

Related Publications

R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
November 1988, European journal of pharmacology,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
August 1996, The American journal of physiology,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
July 1991, The Journal of pharmacology and experimental therapeutics,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
November 1986, Canadian journal of physiology and pharmacology,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
February 1990, The American journal of physiology,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
September 1998, Anesthesia and analgesia,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
January 1960, Minerva nipiologica,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
January 1960, Minerva nipiologica,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
September 1970, Journal of medicinal chemistry,
R M Wheatley, and S P Dockery, and M A Kurz, and H S Sayegh, and D G Harrison
June 1955, Munchener medizinische Wochenschrift (1950),
Copied contents to your clipboard!